Successful endonasal dacryocystorhinostomy in a patient with Wegener’s granulomatosis by Eloy, P et al.
© 2009 Eloy et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Ophthalmology
Clinical Ophthalmology 2009:3 651–656 651
Dovepress
open access to scientific and medical research
Open Access Full Text Article
submit your manuscript | www.dovepress.com
Dovepress 
C A s E   r E P O rT
successful endonasal dacryocystorhinostomy 





ENT and HNs department, Cliniques 
Universitaires de Mont-Godinne, 
Université Catholique de Louvain, 
5530, Yvoir, Belgium
Correspondence: Philippe Eloy 
HNs and ENT department, Cliniques 
Universitaires de Mont-Godinne, 
Université Catholique de Louvain, 
5530,   Yvoir, Belgium 
Fax +32 81 423 703 
Email philippe.eloy@uclouvain.be
Abstract: Wegener’s granulomatosis (WG) is one form of idiopathic autoimmune vasculitis. 
The disease has a predilection for the upper and lower respiratory tracts (lungs, nose, sinus), 
and kidneys. WG may be systemic, severe, and potentially lethal, but it may also be limited to 
the otolaryngological area or to the eyes and the orbits. Obstruction of the lacrimal pathway 
is a possible complication of the disease that affects approximately 7% of patients with WG. 
It usually occurs as a direct extension of sinonasal disease and typically is a late manifestation. 
Management of such a condition is generally viewed as difficult. We report the case of a patient 
with a quiescent WG limited to the otolaryngological area. This patient presented a bilateral 
obstruction of the nasolacrimal ducts caused by bilateral extensive adhesions in the nasal cavity. 
Because she had several episodes of left-side acute dacryocystitis which necessitated several 
courses of broad-spectrum antibiotics, she successfully underwent an endonasal endoscopic 
dacryocystorhinostomy using a diode laser and powered instrumentation. The authors describe 
the clinical case, the surgical technique, and review the literature.
Keywords: Wegener’s granulomatosis, recurrent dacryocystitis, endonasal DCR, diode, laser, 
powered instrumentation
Introduction
Wegener’s granulomatosis (WG) is a rare chronic autoimmune disease characterized 
by the triad of small vessel necrotizing vasculitis, “geographic” necrosis and 
granulomatous inflammation.1 Although it can involve any organ system (eyes, heart, 
skin, joints, nervous system), WG mainly affects the upper and lower respiratory tracts 
(nose, sinus, ears, trachea, and lungs) and kidneys.1–4 The degree of organ involvement 
is highly variable. WG may be limited to a single organ (typically the lungs or upper 
respiratory tract).5 WG affects men and women equally. The average age of onset is 
50 years, but it can occur at almost any age. The etiology is unknown.
At the onset of the disease, the clinical presentation is nonspecific and can vary. 
As the disease progresses, the history becomes more typical and patients develop the 
classic clinical triad of sinusitis–pulmonary symptoms–renal insufficiency.
The definitive diagnosis of WG usually requires a combined assessment of 
the patient’s health history (symptoms), blood and urine tests, imaging, and tissue 
biopsy.2–4
The presence of antineutrophil cytoplasmic antibodies (ANCAs) that react with 
the enzyme proteinase 3 (c-ANCAs) in neutrophils is relatively specific for WG. Their 
determination can help to confirm the diagnosis. Nevertheless, positive ANCAs are 
not conclusive and negative ANCAs are not sufficient to reject the diagnosis. c-ANCA Clinical Ophthalmology 2009:3 652
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titers parallel disease activity and rising titers may herald 
relapse of disease. Perinuclear-staining ANCAs (p-ANCA) 
are seen in a wide variety of vasculitis and are of much lower 
clinical utility.5,6
The very early presence of red blood cells and casts can 
hint at a glomerulonephritis which can evolve into renal 
insufficiency. When clinical and serologic findings are incon-
clusive, tissue biopsy is necessary.
However, a pathological diagnosis can be very difficult 
to establish because all the characteristic diagnostic findings 
(necrosis, vasulitis, and granulomas) are rarely present 
together. Indeed, Devaney and colleagues reported that 
vasculitis, necrosis, and granulomatous inflammation 
together were seen in only 16% of all head and neck biopsy 
specimens. Both vasculitis and granulomatous inflammation 
were seen in 21% and vasculitis and necrosis in 23% of the 
biopsy specimens reviewed.7 Raynaud and colleagues found 
that head and neck biopsies usually have a low diagnostic 
value in WG.8,9 Ninety percent of nasal systematic biopsies 
performed under local anesthetic are nonspecific. For Del 
Buono10 and Maguchi,11 nasal biopsy is relevant for the diag-
nosis in only 50% of patients. To be more contributive, the 
biopsy must be large and targeted on macroscopic lesions. 
When there is no lesion, samples from paranasal sinuses 
obtained under general anesthetic have the highest diagnostic 
value in the head and neck region.8
A multidisciplinary approach should be used to treat 
this multisystem disease.4,12 Treatment involves the use of 
various regimens of corticosteroids and immunosuppres-
sive medication. Mortality due to WG has been significantly 
decreased by this therapy but a significant rate of relapse 
and profound disease- and/or treatment-related morbidity 
still occur.1,3,4,9
The authors report the case of a patient with recurrent 
acute dacryocystitis and a quiescent WG limited to the oto-
laryngological area successfully treated with an endonasal 
endoscopic dacryocystorhinostomy.
Case report
A 35-year-old woman was referred to the Ear-Nose-Throat 
(ENT) department for lacrimal surgery. Figure 1A shows the 
preoperative view of the patient with a saddle-nose deformity 
and a dacryocystocele. For two years, she had been experienc-
ing bilateral epiphora. Her left-sided epiphora was associated 
with recurrent episodes of acute dacryocystitis. These episodes 
necessitated repetitive administrations of broad-spectrum 
antibiotics. Her episodes became more painful over time and 
the last was complicated by a dacryocele. The clinical signs 
did not disappear with medical treatment (oral broad-spectrum 
antibiotics: amoxycyline plus clavulanic acid 875 mg three 
times daily and topical antibiotic eyedrops). A micropuncture 
was performed in order to relief the pain. A culture did not 
grow any bacteria. After a couple of days, the pain decreased 
but unfortunately the dacryocele and epiphora persisted. 
A dacryoscan was performed. It confirmed that the lacrimal 
problem was caused by a nasolacrimal duct obstruction. 
Figures 1C and 1D show two coronal views of a dacryoscan. 
The lacrimal obstruction was caused by extensive adhesions 
developed between the nasal septum and the inferior meatus. 
The decision was then to perform a dacryocystorhinostomy 
under general anesthesia taking into consideration the patient’s 
health history and her modified nasal anatomy.
The patient had a known history of Wegener’s granulo-
matosis. Figures 1A and 1B show the changes of the nasal 
anatomy due to the vasculitis. The disease started in 1997 
with otolaryngological manifestations that included recurrent 
otitis media, rhinitis, and recurrent infections. After several 
relapses, the disease became stable and quiescent. Since 
2005, the patient had been taking Ledertrexate (methotrexate; 
6 × 2.5 mg/1 ×/week). As consequences of the vasculitis, the 
patient ended up with a saddle nose deformity without any 
septal perforation, extensive adhesions in both nasal cavities 
and subglottic stenosis. The patient underwent surgery for 
the synechiae in 2004 at another hospital but unfortunately 
the synechiae recurred in the early postoperative period. The 
synechiae reduced the nasal airflow (as shown in Figure 1B) 
and caused bilateral obstruction of the nasolacrimal duct. The 
patient had subglottic stenosis and her airway diameter was 
reduced to 40%. Fortunately the stenosis was stable and had 
not become worse for four years. The patient did not have 
signs of renal nor pulmonary insufficiency. ANCAs titers 
were negative.
The nasal endoscopy confirmed the extent of the adhe-
sions and the absence of a nasal septum perforation. After 
discussing the issues with the patient, a dacryocystorhinos-
tomy was performed on the left side only under general 
anesthesia using a laryngeal mask rather than a conventional 
endotracheal tube to minimize the risk of reactivation of 
the subglottic stenosis. An endonasal approach was per-
formed using rigid telescopes, diode laser, and powered 
instrumentation. Prior to surgery, the patient had been 
counseled about the possibility of switching to an external 
approach during surgery if necessary.
The nasal cavity was prepared by placing some neurosur-
gical pledgets soaked with a potent decongestant (xylocaine 
5% plus naphazoline) for 15 minutes before the surgery. Clinical Ophthalmology 2009:3 653
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The adhesions were then cut under endoscopic guidance 
(30° -4 mm Hopkins rigid telescope) using the diode laser 
(6030 – laser fiber diameter: 600 microns; Lumenis, Yokneam, 
Israel). Then the entire lacrimal duct was exposed by drilling 
the posterior aspect of the frontal process of the maxilla with 
a dedicated protected drill (XPS – 2.9 mm angulated diamond 
drill for dacryocystorhinostomy; Medtronic, Minneapolis, 
MN, USA). The mucosa of the lacrimal pathway was incised 
with a sickle knife and pus was expressed. The surgical 
opening was located superior to the adhesions. At the end 
of surgery, a bicanalicular silicone tubing and silastic splint 
were left in place in the left nasal fossa for six weeks. Culture 
did not yield bacteria. Histolopathological examination of 
the biopsies taken during the surgery did not show any sign 
of active WG. During the early postoperative period, the 
dosage of the immunosuppressive treatment was increased 
for three weeks in order to avoid any possible rebound of 
the vasculitis.
The patient was free of ophthalmological symptoms 
on the left side six months after the procedure. Figure 2 
illustrates the postoperative result. The dacryocele disap-
peared and the patient did not experience any new episode 
of infection (Figure 2A). The laryngeal stenosis was stable 
and did not need any further surgery such as tracheotomy 
or laser surgery. A postoperative dacryoscan confirmed 







Figure 1 A) Preoperative view of the patient showing a dacryocele (black arrows) and a saddle-nose deformity (white arrows), consequences of a Wegener’s granulomatosis. 
B) Nasal endoscopy of the left nasal cavity. Extensive adhesions developed between the nasal septum and the inferior turbinate reducing dramatically the diameter of the 
nasal cavity. C) Preoperative sinus CT scan showing bilateral extensive adhesions in the nose (white arrows). D) Preoperative dacryoscan showing an opacification of all the 
lacrimal outflow system (white arrows).
Abbreviations: Adh, adhesions; CT, computed tomography; IT, inferior turbinate; s, nasal septum.Clinical Ophthalmology 2009:3 654
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The adhesions recurred slightly but the nasal patency 
was still better than the one observed preoperatively 
(Figure 2B).
Discussion
In its classic presentation, WG is a multiorgan systemic vas-
culitis but the disease may be limited to a single organ, eg, the 
upper respiratory tract.5,13 According to Stone,5 there are sig-
nificant differences between the limited and severe forms of 
the disease. Indeed, patients with limited disease are nearly a 
decade younger at disease onset compared with patients with 
severe disease. 58% of patients with limited WG are women. 
Patients with limited disease tend to have longer disease 
duration, a greater likelihood of experiencing exacerbation of 
previous disease following a period of remission and a higher 
prevalence of destructive upper respiratory tract disorders at 
the time of enrollment (eg, saddle-nose deformity). In such a 
limited form, ANCA titers are usually negative.5,6 Our case 
illustrates all these data perfectly well.
Otolaryngological manifestations are very common in 
WG, affecting more than 80% of the patients.13–15 These 
manifestations can either be the initials signs of the disease 
and/or the only ones. Therefore, clinicians should have a 
high index of suspicion when the patient has a long-lasting 
history of unspecific symptoms, such as chronic nasal 
pain, stuffiness, nosebleeds, chronic discolored rhinorhea, 
rhinitis, long-lasting crusting, saddle-nose deformity, septal 
perforation, and extensive adhesions. Subglottic stenosis may 
be another consequence of the disease causing hoarseness, 
shortness of breath, or cough.14–18 Blockage of the Eustachian 
tube can lead to a conductive hearing loss.
Ophthalmologic manifestations are also common 
in WG and may be the presenting feature.5–7,19–21 They 




Figure 2  A) Postoperative view of the patient confirming the disappearance of the dacryocele (black arrows). B) Postoperative endoscopy of the left nasal cavity showing the 
absence of recurrence of the adhesions posteriorly. C and D) Postoperative dacryoscan confirming the patency of the surgical opening on the left side: presence of medium 
contrast in the nasal cavity (white arrow).Clinical Ophthalmology 2009:3 655
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severe inflammation with keratitis, scleritis, uveitis, and 
retinal vasculitis. They usually respond well to systemic 
antiinflammatory and immunosuppressive agents rather 
than to a topical medical treatment. Involvement of orbital 
tissues can lead to double vision, decrease in vision, or even 
blindness. These complications require immediate medical 
attention. Orbital decompression may be indicated.
Involvement of the lacrimal pathway can be another 
issue of the disease, affecting approximately 7% of the 
patients. This can be caused by a granulomatous inflam-
mation of the paranasal sinus but is more commonly the 
consequence of adhesions blocking the nasolacrimal duct. 
This usually occurs as a late manifestation. Our clinical case 
illustrates such a complication. The patient may complain of 
epiphora, sometimes in conjunction with recurrent infections 
(dacryocystitis). The former is usually better tolerated than 
the latter which commonly leads to surgery.
Lacrimal surgery in WG is considered difficult and often 
has poor outcomes.22,23 Currently, lacrimal surgery is not 
recommended when the disease (WG) is active because the 
risks of recurrence or extension of the granulomatosis to the 
lacrimal sac, orbit and the skin are high.23,24 Lacrimal surgery 
can be performed in two different ways: dacryocystorhinos-
tomy or dacryocystectomy. Dacryocystorhinostomy consists 
of diverting the lacrimal flow into the nasal cavity via a stoma 
created in front of the attachment of the middle turbinate to 
the lateral nasal wall. This is usually the first surgical option 
recommended. Dacryocystorhinostomy can be performed via 
an external or an endonasal approach.
The external approach is the most commonly performed, 
usually by an ophthalmologist.22–24 This approach is the 
gold standard for the treatment of nasolacrimal duct 
obstruction. The advantage of this approach is the ability 
to create a wide stoma, located high into the nose without 
any consideration of the nasal anatomy. In experienced 
hands and inactive WG, the success rate is high. Rose 
reported excellent results (13/14) in a series of 14 patients 
without significant morbidity.22 Good results have also 
been reported by Hartwig23 and Glatt.25 Nevertheless other 
authors have reported poor outcomes characterized by 
recurrence, wound necrosis, and development of nasocu-
taneous fistula.23,25–27
Dacryocystorhinostomy can also be performed using an 
endonasal approach. With the development of the endona-
sal endoscopic surgery, endonasal dacryocystorhinostomy 
is increasingly performed by both ophthalmologists and 
ENT surgeons to treat low mechanical obstruction of the 
lacrimal pathway.27–30 The procedure is performed quickly, 
in a day clinic setting, and has a high rate of success with 
minimal morbidity.
Endonasal surgery can be more challenging in patients with 
WG. In our case, the surgery ended up being more difficult than 
usual and required specific instrumentation.30,31 The anatomy of 
the nose was altered: the adhesions were extensive and made 
the access to the lacrimal eminence very narrow. The adhesions 
were cut and vaporized with the diode laser (Lumenis 6030). 
This type of surgical laser system is better than the CO2 laser 
in endonasal surgery. The laser energy is delivered through an 
optic fiber and is focused at the tip of the fiber. This reduces 
the risk of burning the skin or the alar cartilages. This laser 
surgical system also provides excellent hemostasis because 
the laser energy is absorbed by blood.32,33 It can also cut and 
vaporize the soft tissue, particularly adhesions. Unfortunately, 
lysis of adhesions created significant blood oozing. This made 
frequent cleaning of the tip of the lens necessary, thus mak-
ing the procedure a little bit longer than usual. In our case, 
because of the adhesions, the stoma was created high in the 
nasal cavity to lower the risk of recurrence. The stoma was 
located superior to the adhesions, at the level of the root of 
the middle turbinate. The technique we used was described 
previously.30 We used powered instrumentation (Xomed XPS 
microdebrider; Medtronic) with a dedicated angulated and 
protected diamond drill for dacryocystorhinostomy, angulated 
telescope (30° rigid telescope) and forceps. The advantages 
of this surgical approach and technique were to avoid a skin 
incision with its potential risk of necrosis, to preserve the 
lacrimal function by avoiding dissection of the medial canthus 
structures, to rehabilitate the nasal function by improving the 
nasal patency and to create enough space in the nose to be able 
to stop any possible intraoperative hemorrhage by packing. 
One potential disadvantage of this technique is the cost of the 
necessary equipment. Fortunately, many ENT surgeons have 
these devices within their department.
Another treatment option consists of performing a 
dacryocystectomy.27 This was proposed by Holds and 
Anderson as an alternative to dacryocystorhinostomy for 
dacryocystitis in patients with WG in whom epiphora was 
not a major concern because they had several cases of failure 
or complications after external dacryocystorhinostomy. We 
recommend reserving this procedure for revision surgery 
in the event of failure of either an endonasal or external 
dacryocystorhinostomy.
Conclusion
This case illustrates that an endonasal endoscopic dacryo-
cystorhinostomy can be successful in a patient with WG and Clinical Ophthalmology 2009:3
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extensive adhesions provided that the stoma is created very 
high into the nose, superior to the adhesions. The surgery 
requires the use of angulated telescopes, lasers, and powered 
instrumentation. It must be performed when WG is quiescent 
by a surgeon with expertise in endonasal surgery.
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